Do you know how biomarkers can support diagnosis, guide treatment selection, and monitor progress in early-stage Alzheimer’s disease?
In these interactive virtual escape rooms, you will answer biomarker-focused questions to unlock clues and receive expert feedback. Use these clues to solve case-based challenges and escape the clinic.
Select your role below to get started.
Primary care physician (PCP) escape room
With Dr Chuck Vega
Psychiatrist escape room
With Prof Robert Perneczky
Advanced practice provider (APP) escape room
With Dr Carolyn Clevenger
Neurologist escape room
With Prof Dorota Religa
Imaging physician escape room
With Prof Hitoshi Shimada
Liked this educational activity?
General information
Title: Escape the clinic
Jointly provided by Postgraduate Institute for Medicine and Springer Health+ IME
Estimated time: 15 minutes per escape room
Target audience
This activity is primarily aimed at dementia specialists, neurologists, geriatricians, geriatric psychiatrists, primary care providers, imaging physicians, advanced practice providers (NPs/PAs), but is relevant to all members of the multidisciplinary team that manage patients with Alzheimer’s disease.
Learning objectives
After completing this module, the participant should be better able to:
- Evaluate the utility of current and emerging biomarkers to support an accurate diagnosis of early-stage Alzheimer’s disease
- Interpret the results of imaging and fluid biomarker tests for early-stage Alzheimer’s disease
- Apply biomarker testing to guide treatment selection for disease-modifying therapies and appropriate treatment monitoring
- Establish a shared decision-making approach that prioritizes empathetic and clear communication with patients and caregivers throughout the biomarker testing process
Faculty
Professor Dorota Religa (Program Director)
Professor / Senior Consultant
Karolinska Institutet, Sweden
Dr Carolyn Clevenger
Professor and Executive Director
Integrated Memory Care, Emory University, United States
Professor Robert Pernezcky
Professor of Translational Dementia Research
LMU Hospital, LMU Munich, Germany
Professor Hitoshi Shimada
Professor
Brain Research Institute, Niigata University, Japan
Dr Chuck Vega
Clinical Professor of Family Medicine
UC Irvine, United States
Disclosure of financial relationships
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified financial relationships are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Professor Dorota Religa (Program Director)
Nothing to disclose
Dr Carolyn Clevenger
Consultant/Advisory Board: Braincheck, Eli Lilly, Novo Nordisk, Otsuka
Professor Robert Pernezcky
Employee/Owner: Medotrax
Grant/Research Support: GSK, Roche
Speakers Bureau/Honoraria for non-CME: Biogen, Eisai, Eli Lilly, Roche, Schwabe, Tabuk
Consultant/Advisory Board: Biogen, Bristol-Myers Squibb, Eisai, Eli Lilly, Roche
Professor Hitoshi Shimada
Grant/Research Support: Shimadzu, Splink
Speakers Bureau/Honoraria for non-CME: Biogen, Eisai, Eli Lilly, Kowa, Kyowa Kirin, Medi-Physicas, Nihon, PDR pharma, Shimadzu, Takeda
Dr Chuck Vega
Consultant/Advisory Board: Boehringer Ingelheim, Exact Sciences
The PIM planners and others have nothing to disclose. The Springer Health+ IME planners and others have nothing to disclose.
All relevant financial relationships have been mitigated.
Accreditation
Accreditation information is available on each individual Escape room page.
Disclosure of unlabeled use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
